Supplementary Figure Legend from Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy

Authors:
  • SWSamuel T. Workenhe
    Samuel T. Workenhe
  • JPJonathan G. Pol
    Jonathan G. Pol
  • BLBrian D. Lichty
    Brian D. Lichty
  • DCDerek T. Cummings
    Derek T. Cummings
  • KMKaren L. Mossman
    Karen L. Mossman

Abstract
No abstract available